Vonicog Alfa 相關新聞
Vonicog Alfa 目前有 0 則相關新聞報導,預測適應症 20 個。
本頁整合 Vonicog Alfa 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
- 原適應症:Prevention and treatment of haemorrhage or surgical bleeding in adults (age 18 years and older) with von Willebrand disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or...
- 證據等級:L5
- 預測適應症(20 個):
- primary release disorder of platelets(100.0%)
- Glanzmann thrombasthenia(100.0%)
- pseudo-von Willebrand disease(100.0%)
- hemophilia(100.0%)
- Scott syndrome(100.0%)
- acquired coagulation factor deficiency(99.9%)
- Von Willebrand disease, X-linked form(99.9%)
- bleeding diathesis due to a collagen receptor defect(99.9%)
- hemorrhagic disorder due to a constitutional thrombocytopenia(99.9%)
- flood factor deficiency(99.9%)
- hereditary thrombocytosis with transverse limb defect(99.9%)
- familial thrombomodulin anomalies(99.9%)
- von Willebrand disease(99.8%)
- inherited thrombophilia(99.8%)
- small bowel Crohn disease(99.8%)
- methylcobalamin deficiency type cblG(99.8%)
- esophageal ulcer(99.8%)
- gastritis(99.7%)
- thrombotic thrombocytopenic purpura(99.7%)
- hemorrhagic disorder due to a coagulation factors defect(99.6%)
相關新聞(0 則)
目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。
免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。